Search Within

Neeta Pandit-Taskar

  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (51)
  2. Meeting Abstract (50)
  3. Book Section (2)
Groups
  1. GSK Faculty (103)
  2. Molecular Imaging and Therapy Service (103)
  3. Molecular Pharmacology and Chemistry Program Faculty (103)
  4. Radiology, Department of (103)
  5. Sloan Kettering Institute Faculty (103)
  6. Medical Physics (62)

More Groups

People
  1. Steven Larson (99)
  2. Jorge Carrasquillo (53)
  3. Pat Zanzonico (35)
  4. Serge Lyashchenko (35)
  5. Michael Morris (30)
  6. Howard Scher (29)

More People

Years
  1. 2025 (1)
  2. 2023 (1)
  3. 2022 (7)
  4. 2021 (3)
  5. 2020 (1)
  6. 2019 (8)

More Years

Publications
  1. Journal of Clinical Oncology (22)
  2. Journal of Nuclear Medicine (21)
  3. Neuro-Oncology (9)
  4. Pediatric Blood and Cancer (8)
  5. Clinical Cancer Research (7)
  6. European Journal of Nuclear Medicine and Molecular Imaging (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (22)
  2. Society of Nuclear Medicine (21)
  3. Springer (14)
  4. American Association for Cancer Research (10)
  5. Oxford University Press (9)
  6. Wiley Periodicals, Inc (8)

More Publishers

Results (103)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety and efficacy of intraventricular (131)I-labeled monoclonal antibody 8H9 targeting the surface glycoprotein B7-H3 in patients with CNS/LM disease
    Meeting Abstract

    Kramer, K.; Kushner, B.; Modak, S.; Pandit-Taskar, N.; Tomlinson, U.; Donzelli, M.; Wolden, S.; Zanzonico, P.; Humm, J.; Haque, S.; more...
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • A phase II study of radioimmunotherapy with intraventricular 131I-3F8 for medulloblastoma
    Meeting Abstract

    Kramer, K.; Pandit-Taskar, N.; Humm, J.; Zanzonico, P.; Haque, S.; Dunkel, I.; Wolden, S.; Donzelli, M.; Goldman, D.; Lewis, J.; more...
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC)
    Journal Article

    Abou-Alfa, G. K.; Yen, C. J.; Hsu, C. H.; O'Donoghue, J.; Beylergil, V.; Ruan, S.; Pandit-Taskar, N.; Gansukh, B.; Lyashchenko, S. K.; Ma, J.; more...
    Cancer Chemotherapy and Pharmacology (2017)

    Fulltext@MSK | Save
  • First-in-human imaging with (89)Zr-Df-IAB2M Anti-PSMA minibody in patients with metastatic prostate cancer: Pharmacokinetics, biodistribution, dosimetry, and lesion uptake
    Journal Article

    Pandit-Taskar, N.; O'Donoghue, J. A.; Ruan, S.; Lyashchenko, S. K.; Carrasquillo, J. A.; Heller, G.; Martinez, D. F.; Cheal, S. M.; Lewis, J. S.; Fleisher, M.; more...
    Journal of Nuclear Medicine (2016)

    Fulltext@MSK | Save
  • First in-human study: 18F-FDG PET/CT positron lymphography maps sentinel lymph nodes in early-stage cervical and endometrial cancer
    Meeting Abstract

    Mueller, J.; Soslow, R.; Jewell, E.; Dauer, L.; John, H.; Pandit-Taskar, N.; Abu-Rustum, N.; Grimm, J.
    International Journal of Gynecological Cancer (2016)

    Fulltext@MSK | Save
  • Evaluation of castration-resistant prostate cancer with androgen receptor-axis imaging
    Journal Article

    Pandit-Taskar, N.; Veach, D. R.; Fox, J. J.; Scher, H. I.; Morris, M. J.; Larson, S. M.
    Journal of Nuclear Medicine (2016)

    Fulltext@MSK | Save
  • A phase I/IIa trial of prostate specific membrane antigen (PSMA) positron emission tomography (PET) imaging with (89)Zr-Df-IAB2M in metastatic prostate cancer (PCa)
    Meeting Abstract

    Morris, M. J.; Martinez, D. F.; Durack, J. C.; Slovin, S. F.; Danila, D. C.; O'Donoghue, J. A.; Parada, N. A.; Lyashchenko, S. K.; Carrasquillo, J. A.; Ruan, S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Arsenic trioxide as a radiation sensitizer for (131)I-metaiodobenzylguanidine therapy: Results of a phase II study
    Journal Article

    Modak, S.; Zanzonico, P.; Carrasquillo, J. A.; Kushner, B. H.; Kramer, K.; Cheung, N. K. V.; Larson, S. M.; Pandit-Taskar, N.
    Journal of Nuclear Medicine (2016)

    Fulltext@MSK | Save
  • A phase I/II study for analytic validation of 89Zr-J591 immunoPET as a molecular imaging agent for metastatic prostate cancer
    Journal Article

    Pandit-Taskar, N.; O'Donoghue, J. A.; Durack, J. C.; Lyashchenko, S. K.; Cheal, S. M.; Beylergil, V.; Lefkowitz, R. A.; Carrasquillo, J. A.; Martinez, D. F.; Fung, A. M.; more...
    Clinical Cancer Research (2015)

    Fulltext@MSK | Save
  • PET-based compartmental modeling of (124)I-A33 antibody: Quantitative characterization of patient-specific tumor targeting in colorectal cancer
    Journal Article

    Zanzonico, P.; Carrasquillo, J. A.; Pandit-Taskar, N.; O'Donoghue, J. A.; Humm, J. L.; Smith-Jones, P.; Ruan, S.; Divgi, C.; Scott, A. M.; Kemeny, N. E.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2015)

    Fulltext@MSK | Save